Manufacturer of the NvisionVLE Imaging System, a commercially available advanced imaging technology for evaluation of the esophagus.
Location: United States, Massachusetts, Bedford
Employees: 51-200
Total raised: $67M
Founded date: 2009
Investors 4
| Date | Name | Website |
| - | Hendale Ca... | hendale.co... |
| 06.11.2022 | Hercules C... | htgc.com |
| - | Prospect V... | prospectve... |
| - | Horizon Te... | horizontec... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 20.03.2014 | Series B | $34M | - |
| 14.10.2010 | Series A | $33M | - |
Mentions in press and media 14
| Date | Title | Description |
| 25.04.2024 | Ninepoint Partners Announces Final Closing of Over $43 Million for Ninepoint 2024 Short Duration Flow-Through Limited Partnership | - |
| 24.10.2023 | Ninepoint Partners Closes 2023 Short Duration Flow-Through LP With Over $20 Million In Proceeds | - |
| 20.04.2023 | Ninepoint Partners Closes 2023 Flow-Through LP With Over $33 Million in Proceeds | - |
| 03.12.2014 | Ex-Boston Scientific CEO Tobin joins Oxford Immunotec board | Personnel Moves | Jim Tobin, the former CEO of Boston Scientific (NYSE:BSX) who oversaw the $27 billion acquisition of Guidant Corp. in 2006, joined the board of directors at Oxford Immunotec Global (NSDQ:OXFD), that company said yesterday. The Oxford, U.K.-... |
| 20.03.2014 | NinePoint Medical Completes $34M Series B | CAMBRIDGE, MA, Emerging leader in the development of medical devices for advanced optical imaging, today announced it has completed a $34 million Series B financing. >> Click here for more funding data on NinePoint Medical >>... |
| 20.03.2014 | NinePoint Medical lands $34M for high-res organ imaging | Massachusetts-based NinePoint Medical Imaging closed a $34 million Series B funding round, the company announced today. NinePoint plans to use the funds to support ongoing U.S. commercial efforts for its NvisionVLE system, which provides hi... |
| 20.03.2014 | NinePoint Medical Completes $34M Series B Financing | NinePoint Medical, a Cambridge, Mass.-based company that develops medical devices enabling high resolution in-vivo imaging, completed a $34m Series B financing. The round was led by Corning Inc. (NYSE: GLW), with participation from founding... |
| 23.07.2013 | With IP from Mass Gen & funding from Third Rock, NinePoint carves niche in in-vivo imaging | Called NvisionVLE, the platform has been cleared by the U.S. Food and Drug Administration. It allows clinicians to look deeper into tissue in the esophagus during an endoscopy. The device uses infrared light, as opposed to white light used ... |
| 16.05.2013 | Third Rock’s Ninepoint Medical Grows Up, Plans $35M Series B | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Ninepoint Medical earned the distinction of becoming the first—and to date, the only—medical device maker seeded by startup creation specialist Third Rock Ventures when it set... |
| 13.12.2010 | NinePoint licenses IP trove from Mass. General Hospital | NinePoint Medical Inc. entered into a licensing deal with Mass. General Hospital for 188 patents and patent applications owned by the institution. The Cambridge, Mass.-based company plans to incorporate the intellectual property into its hi... |
Show more